All In Biotech

Drug Trial Radar · NCT06860971

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

A Randomized, Double-Blind, Multicenter Phase III Clinical Trial Evaluating AL2846 Capsule Versus Placebo in Patients With Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma Who Failed Prior VEGFR-Targeted Therapy

Last checked: Nov 19, 2026Latest source record: Dec 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 144 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

144

Planned (sponsor's estimate)

Start

Apr 18, 2025

Primary completion

Jan 2027

Study completion Jan 2028

Sponsor

Sponsor type
Industry
First posted
Mar 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to demonstrate that, in subjects with locally advanced or metastatic iodine - refractory differentiated thyroid cancer who have failed previous VEGFR - targeted therapy, AL2846 can significantly prolong progression - free survival (PFS) compared with placebo.

Conditions

  • Thyroid Cancer

Interventions

  • AL2846 CapsulesDrug

    AL2846 Capsule is a multi - target tyrosine kinase inhibitor, which has significant inhibitory effects on c-Mesenchymal-epithelial transition factor (c - MET), stem cell factor receptor (c - KIT), VEGFR1 and Ret Proto-Oncogene (RET).

  • AL2846 PlaceboDrug

    AL2846 Placebo without drug substance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression - Free Survival (PFS) evaluated by the Independent Review Committee (IRC)Time frame: 34 months

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Hospital Of Anhui Medical University

    Hefei, Anhui, China · Not yet recruiting

  • cancer hospital Chinese academy of medical sciences

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The Southwest Hospital of Amu

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • Gansu Provincial Cancer Hospital

    Lanzhou, Gansu, China · Not yet recruiting

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China · Not yet recruiting

  • Affiliated Hospital of Guilin Medical University

    Gui'lin, Guangxi, China · Not yet recruiting

  • The Second Affiliated Hospital Of GXUST

    Liuzhou, Guangxi, China · Not yet recruiting

  • The First Affiliated Hospital of Hainan Medical University

    Hainan, Haikou, China · Not yet recruiting

  • CangZhou Center Hospital

    Cangzhou, Hebei, China · Not yet recruiting

  • Harbin Medical University cancer hospital

    Harbin, Heilongjiang, China · Not yet recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Not yet recruiting

  • Nanjing First Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • The Affiliated Hospital of XuZhou Medical University

    Xuzhou, Jiangsu, China · Not yet recruiting

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Not yet recruiting

  • JIANGXI cancer hospital

    Nanchang, Jiangxi, China · Not yet recruiting

  • China-Japan Union Hospital of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • JILIN cancer hospital

    Changchun, Jilin, China · Not yet recruiting

  • Liaoning Cancer Hospital

    Shengyang, Liaoning, China · Not yet recruiting

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    Xi'an, Shaani, China · Not yet recruiting

  • Xijing Hospital

    Xi'an, Shaanxi, China · Not yet recruiting

  • Shaanxi Provincial People'S Hospital

    Xi'an, Shaanxi, China · Not yet recruiting

  • The Second Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • Shandong Cancer Hospital

    Jinan, Shandong, China · Not yet recruiting

  • Weifang people's Hospital

    Weifang, Shandong, China · Not yet recruiting

  • Shanghai Sixth People's Hospital

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Shanghai Jiaotong University School of Medicine, Tongji Hospital

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • West China Hospital of Si chuan University

    Chengdu, Sichuan, China · Not yet recruiting

  • Tianjin Cancer Hospital Airport Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • Tianjin Medical University Cancer Institute&Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Affiliated Tumor Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China · Not yet recruiting

  • Yunnan Cancer Hospital

    Kunming, Yunnan, China · Not yet recruiting

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.